|
2025
|
Invention
|
Compositions targeting prostate-specific membrane antigen and methods for making and using the sa... |
|
|
Invention
|
Compositions targeting epidermal growth factor receptor and methods for making and using the same... |
|
2024
|
Invention
|
Antibodies and assays for determining clotting factor viii activity. The present disclosure provi... |
|
|
Invention
|
Protease activatable cytokines and methods for making and using the same. Provided herein are, in... |
|
|
Invention
|
Binding fusion proteins, binding fusion protein-drug conjugates, xten-drug conjugates and methods... |
|
|
Invention
|
Extended recombinant polypeptides and compositions comprising same.
The present invention relate... |
|
|
Invention
|
Release segments and binding compositions comprising same.
The present invention relates to acti... |
|
|
Invention
|
Chimeric polypeptide assembly and methods of making and using the same.
The present invention re... |
|
|
Invention
|
Compositions targeting prostate-specific membrane antigen (psma) and methods for making and using... |
|
2023
|
Invention
|
Her-2 targeted bispecific compositions and methods for making and using the same. Disclosed herei... |
|
|
P/S
|
Scientific and technological services, namely, chemical, biological, medical, pharmaceutical and ... |
|
|
Invention
|
Glucagon-like peptide-2 compositions and methods of making and using same.
The present invention... |
|
|
Invention
|
Xten conjugate compositions and methods of making same.
The present invention relates to extende... |
|
2022
|
Invention
|
Compositions and methods related to activatable therapeutic agents.
Described herein are methods... |
|
|
Invention
|
Chimeric polypeptide assembly and methods of making and using the same. The present invention rel... |
|
|
Invention
|
Her-2 targeted bispecific compositions and methods for making and using the same.
Disclosed here... |
|
|
Invention
|
Cytokine conjugates.
The present invention relates to compositions comprising biologically activ... |
|
|
P/S
|
Biomedical compounds, namely, polypeptides for providing half-life extension; biomedical compound... |
|
|
P/S
|
Chemical preparations for use in the manufacture of pharmaceuticals; diagnostic reagents for scie... |
|
2021
|
P/S
|
Chemicals used in the manufacture of pharmaceuticals; reagents, enzymes, and nucleotides for scie... |
|
|
P/S
|
Protein polymeric intermediates for use in the manufacture of pharmaceutical preparations; chemic... |
|
|
P/S
|
Chemicals used in the manufacture of pharmaceuticals; biomedical compounds, namely, polypeptides ... |
|
|
P/S
|
Chemicals used in the manufacture of pharmaceuticals; biomedical compounds, namely, recombinant a... |
|
|
Invention
|
Compositions and methods related to activatable therapeutic agents. Described herein are methods ... |
|
|
Invention
|
Cytokine conjugates. The present invention relates to compositions comprising biologically active... |
|
|
Invention
|
Coagulation factor ix compositions and methods of making and using same.
The present invention r... |
|
|
Invention
|
Extended recombinant polypeptides and compositions comprising same. The present invention relates... |
|
2020
|
Invention
|
Barcoded xten polypeptides and compositions thereof, and methods for making and using the same.
... |
|
|
Invention
|
Barcoded xten polypeptides and compositions thereof, and methods for making and using the same. D... |
|
|
Invention
|
Egfr antigen binding fragments and compositions comprising same.
The present disclosure related ... |
|
|
Invention
|
Cd3 antigen binding fragments and compositions comprising same.
This disclosure relates to compo... |
|
|
Invention
|
Cd3 antigen binding fragments and compositions comprising same. This disclosure relates to compos... |
|
|
Invention
|
Egfr antigen binding fragments and compositions comprising same. The present disclosure related t... |
|
2018
|
Invention
|
Release segments and binding compositions comprising same. The present invention relates to activ... |
|
|
Invention
|
Xten conjugate compositions and methods of making same. The present invention relates to extended... |
|
2017
|
Invention
|
Treatment of adult growth hormone deficiency with human growth hormone analogues.
The present di... |
|
|
Invention
|
Blood glucose lowering compound. The present invention relates to the field of medicine and the t... |
|
2016
|
Invention
|
Glucose-regulating polypeptides and methods of making and using same. The present invention relat... |
|
2015
|
Invention
|
Targeted xten conjugate compositions and methods of making same.
The present disclosure provides... |
|
|
Invention
|
Growth hormone polypeptides and methods of making and using same. The present invention relates t... |
|
2014
|
P/S
|
Protein polymeric intermediates for use in the manufacture of pharmaceutical preparations Pharmac... |
